With the adoption of a patient-centric approach by the Pharma Industry, “Trials of the Future” are Decentralized Clinical Trials are predominantly hybrid or remote. Digital tools like ePRO, eConsent, Digital Communication tools, Mobile Applications, POCT (Point of Care Testing), Connected devices, Remote Patient Monitoring as well as integration with RTSM and Telemedicine platforms are increasingly being adopted during the trial cycle.  Patient engagement & retention with improved therapy adherence is critical across the patient journey. The global Decentralized Clinical Trials (DCTs) market size is projected to reach US$ 18950 million by 2028, from US$7135 million in 2021, at a CAGR of 14.8% during 2022-2028.